Adenosine deaminase enhances the immunogenicity of human dendritic cells from healthy and HIV-infected individuals.
ADA is an enzyme implicated in purine metabolism, and is critical to ensure normal immune function. Its congenital deficit leads to severe combined immunodeficiency (SCID). ADA binding to adenosine receptors on dendritic cell surface enables T-cell costimulation through CD26 crosslinking, which enha...
Guardado en:
Autores principales: | Víctor Casanova, Isaac Naval-Macabuhay, Marta Massanella, Marta Rodríguez-García, Julià Blanco, José M Gatell, Felipe García, Teresa Gallart, Carme Lluis, Josefa Mallol, Rafael Franco, Núria Climent, Peter J McCormick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5b2016ec1294af0bcdc5275b1d538a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.
por: Marta Rodríguez-García, et al.
Publicado: (2010) -
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells
por: Hugh S. Gannon, et al.
Publicado: (2018) -
Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis
por: Sai Krishna Srimadh Bhagavatham, et al.
Publicado: (2021) -
A Case of Deficiency of Adenosine Deaminase 2: 28 years of Diagnostic Challenges
por: Clara Pardinhas, et al.
Publicado: (2021) -
Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations
por: Reem Albalawi MSc, et al.
Publicado: (2021)